Ochranné známky

Níže jsou uvedeny ochranné známky produktů a jejich vlastníci, kteří jsou uvedení na webových stránkách společnosti Bristol Myers Squibb. Ochranné známky společnosti Bristol Myers Squibb zahrnují ochranné známky jejích divizí a dceřiných společností.
 

Pozn.: Některé z níže uvedených léčivých přípravků nemusí být dostupné na trhu v České republice.
 

ABILIFY® (aripiprazole) – Otsuka Pharmaceutical Co., Ltd.

ABECMA® (idecabtagene vicleucel) – Bristol-Myers Squibb Company

ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) – Bristol-Myers Squibb Company

ATRIPLA® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) – Gilead Sciences LLC

AVAPRO® (irbesartan) – Sanofi

AZACTAM® (aztreonam) – Bristol-Myers Squibb Company

BARACLUDE® (entecavir) – Bristol-Myers Squibb Company

BREYANZI® (lisocabtagene maraleucel) – Bristol-Myers Squibb Company

BICNU® (carmustine) – Emcure Pharmaceuticals Limited

BLENOXANE® (bleomycin sulfate)* – Bristol-Myers Squibb Company

BUFFERIN®  – Genomma Lab USA, Inc.

BUSPAR® (buspirone)* – Bristol-Myers Squibb Company

CAMZYOSTM (mavacamten) – Bristol-Myers Squibb Company

CAPOTEN® (captopril) – Par Pharmaceutical, Inc

CARDIOLITE® (Kit for the preparation of technetium tc99m sestamibi) – Lantheus Medical Imaging, Inc.

CEENU® (lomustine)* – Bristol-Myers Squibb Company

CEFZIL® (cefprozil)* – Bristol-Myers Squibb Company

CELMoDTM - Bristol-Myers Squibb Company

CLAIROL® - Wella Operations US, LLC

DROXIA® (hydroxyurea) – Bristol-Myers Squibb Company

ELIQUIS® (apixaban) – Bristol-Myers Squibb Company

EMPLICITI® (elotuzumab) – Bristol-Myers Squibb Company

ERBITUX® (cetuximab) – ImClone LLC

EVOTAZ® (atazanavir and cobicistat) – Bristol-Myers Squibb Company

EXCEDRIN® Migraine – GSK Consumer Healthcare SARL

GLUCOPHAGE® (metformin hydrochloride) – Merck Sante

GLUCOPHAGE XR® EXTENDED RELEASE (metformin hydrochloride) – Merck Sante

GLUCOVANCE® (glyburide and metformin hydrochloride)* – Merck Sante

HYDREA® (hydroxyurea) – Bristol-Myers Squibb Company

IDHIFA® (enasidenib)    – Bristol-Myers Squibb Company

IMNOVID® (pomalidomide) – Bristol-Myers Squibb Company

INREBIC® (fedratinib) – Bristol-Myers Squibb Company

IPANA® – Maxill, Inc.

ISTODAX® (romidepsin) – Bristol-Myers Squibb Company

IXEMPRA® (ixabepilone) – R-Pharm US Operating, LLC 

KENALOG®-10 (triamcinolone acetonide) – Bristol-Myers Squibb Company

KENALOG®-40 (triamcinolone acetonide) – Bristol-Myers Squibb Company

KOMBIGLYZE®  XR (saxagliptin and metformin hydrochloride)* – AstraZeneca AB 

LYSODREN® (mitotane) – Laboratoire HRA-Pharma SAS

MEGACE® (megestrol acetate) – Bristol-Myers Squibb Company

METAGLIP® (glipizide and metformin hydrochloride)* – Merck Sante

MONOPRIL® (fosinopril sodium)* – Bristol-Myers Squibb Company

MUTAMYCIN® (mitomycin)* – Bristol-Myers Squibb Company

NULOJIX® (belatacept) - Bristol-Myers Squibb Company

ONGLYZA® (saxagliptin) – AstraZeneca AB

OPDIVO® (nivolumab) – Bristol-Myers Squibb Company

OPDUALAGTM (nivolumab and relatlimab-rmbw) – Bristol-Myers Squibb Company

ONUREG® (azacitidine tablets) – Bristol-Myers Squibb Company

ORENCIA® (abatacept) – Bristol-Myers Squibb Company

PARAPLATIN® (carboplatin)* – Bristol-Myers Squibb Company

PLAVIX® (clopidogrel bisulfate) – Sanofi 

PLATINOL® (cisplatin)* – Bristol-Myers Squibb Company*

POMALYST® (pomalidomide) – Bristol-Myers Squibb Company

REBLOZYL® (luspatercept-aamt) – Bristol-Myers Squibb Company  

REVLIMID® (lenalidomide) – Bristol-Myers Squibb Company

REYATAZ® (atazanavir sulfate) – Bristol-Myers Squibb Company

SAL HEPATICA® - Alper Holdings Inc.

SINEMET® (carbidopa-levodopa) – Merck Sharpe & Dohme Corp.

SINEMET CR® (carbidopa-levodopa)* – Merck Sharpe & Dohme Corp.

SOTYKTUTM (deucravacitinib) – Bristol-Myers Squibb Company

SPRYCEL® (dasatinib) – Bristol-Myers Squibb Company

SUSTIVA® (efavirenz) – Bristol-Myers Squibb Pharma Company

TAXOL® (paclitaxel)* – Bristol-Myers Squibb Company

TEQUIN® (gatifloxacin)* – Bristol-Myers Squibb Company

THALOMID® (thalidomide) – Bristol-Myers Squibb Company

VEPESID® (etoposide)* – Bristol-Myers Squibb Company

VIDAZA® (azacitidine) – Bristol-Myers Squibb Company

YERVOY® (ipilimumab) – Bristol-Myers Squibb Company

ZEPOSIA® (ozanimod) – Bristol-Myers Squibb Company


NO-CZ-2300008